推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 據(jù)知情人士透露，萬華化學(xué)(600309.SH)原計(jì)劃6月底開啟的環(huán)氧丙烷及丙烯酸酯一體化裝置，將推遲一個月至7月底試生產(chǎn)，但原因不明。
大智慧通訊社(微信號DZH_news)據(jù)此咨詢?nèi)f華化學(xué)證券事務(wù)部，其內(nèi)部人士回應(yīng)稱，環(huán)氧丙烷一體化裝置開啟時間推遲屬實(shí)，但確切開啟時間暫不明確，一旦該一體化裝置全線打通后將會公告。
萬華化學(xué)是聚氨酯行業(yè)龍頭企業(yè)，2011年公告建設(shè)八角工業(yè)園配套項(xiàng)目-環(huán)氧丙烷及丙烯酸酯一體化項(xiàng)目，該項(xiàng)目包括建設(shè)60萬噸丙烷脫氫制丙烯(PDH)、24萬噸環(huán)氧丙烷(PO)、22.5萬噸丁醇、30萬噸丙烯酸及配套的丙烯酸酯和30萬噸聚醚裝置及其它輔助工程和公用工程，總投資148.8億元。
國聯(lián)證券研究報告顯示，根據(jù)目前監(jiān)測的丙烯-1.2*丙烷的價差，PDH裝置生產(chǎn)的每噸丙烯的毛利在2000元左右，再加上副產(chǎn)氫氣的再利用，百萬立方米洞窟的存儲優(yōu)勢，滿產(chǎn)后有望為公司帶來18億的凈利;目前我國PO競爭格局良好，公司產(chǎn)業(yè)鏈成本優(yōu)勢明顯，有望為公司帶來6億左右的凈利。這兩個產(chǎn)業(yè)鏈合計(jì)將為公司貢獻(xiàn)24億左右的凈利。而公開資料顯示，萬華化學(xué)2014年全年共實(shí)現(xiàn)凈利潤約24億元。
